Mr Baker is a commercial advisor and company director with over 40 years of experience in law, investment banking, public company leadership and corporate governance. He has deep industry knowledge across a range of sectors and understanding of financial markets. Mr Baker is a co-founder of Baker Cook Advisory which is a boutique provider of outsourced legal, commercial and governance advice and mediation services for corporations and government agencies.

Ms Patterson has over 20 years of experience in business and corporate strategy with exposure in Australia and international markets. She has developed a number of businesses from start-up as well as driving established organisations. Jo has held multiple CEO and Managing Director roles over her career.

Mr Livery has over 25 years of experience in senior roles domestically and internationally. Most relevant are his last seven years as director of strategy and corporate development at Swisse Wellness Group, a market leading wellness brand. In addition, George's executive experience is culminated in positions across multiple other industries including the role of chief executive officer at Village Cinemas Australia, chief operating officer of Village International, commercial director at Hoyts Limited, and director of operations and marketing (non-academic services) at the University of Sydney.

Mr Bedi is Group Senior Director of Strategy and Corporate Affairs at H&H Group. He is based in Hong Kong and is responsible for leading H&H Group's strategy and business development including mergers and acquisitions, and strategic investments for NewH2. He has extensive experience in investing in global start-ups and high growth companies with technologies and businesses that are of strategic importance to H&H Group. Akash has experience in multicultural and global environments. Prior to joining H&H Group, he was a Director of Global Consumer and Retail for HSBC for over a decade.

Mr Masterson has two decades of experience in the pharmaceutical and healthcare sectors. He began his career with Johnson & Johnson before joining global healthcare giant, Abbott Laboratories (NYSE: ABT) where he held multiple senior positions. Mark also held the role of CEO with Australia's largest private diagnostic imaging network, I-MED. Following the acquisition of I-MED, he was appointed Chairman of Medicines Australia.

Mr Cappon has experience in biochemistry, nutrition, health and innovation. He has a background in chemistry, life sciences, nutrition and health innovation and developing new consumer and healthcare solutions for commercialization. Mr Cappon is currently Chief Technology Officer at H&H, a position which he has held since January 2021. Mr Cappon's previous senior roles with international companies include VP R&D Nutritionals & Digestive Health at Bayer Consumer Health, Switzerland, as well as VP R&D Nutricia Medical Nutrition at multinational food company Danone Nutricia, Netherlands, amongst others.

-

-

-